journal cover

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma

Oncoimmunology

Jan 25, 2019

Tanner M JohannsGavin P Dunn

Get paper from

Abstract

Neoantigens represent promising targets for personalized cancer vaccine strategies. However, the feasibility of this approach in lower mutational burden tumors like glioblastoma (GBM) remains unknown. We have previously reported the use of an immunogenomics pipeline to identify candidat...read more

Mentioned in this Paper

Glioblastoma
HLA Antigens
Interferons
Lymphocyte
Neoplasms
T-Lymphocyte
Vaccination
Vaccines
Peripheral Blood
Cancer Vaccines
7
41
1
1
Paper Details
References
  • References
  • Citations1
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.

Similar Papers Found In These Feeds

Human Tumor Atlas Network (HTAN)

The Human Tumor Atlas Network is a collaborative network that aims to construct 3D atlases of the cellular, morphological, and molecular features of human cancers over time. Here is the latest research from researchers in the Human Tumor Atlas Network.

Interferon Signalling

Via interaction with their specific receptors, interferons (IFNs) activate signal transducer and activator of transcription (STAT) complexes. STAT activation initiates the classical Janus kinase-STAT (JAK-STAT) signaling pathway. In this pathway, JAKs associate with IFN receptors and, following receptor engagement with IFN, phosphorylate both STAT1 and STAT2. As a result, an IFN-stimulated gene factor 3 (ISGF3) complex forms—this contains STAT1, STAT2 and a third transcription factor called IRF9—and moves into the cell nucleus. Inside the nucleus, the ISGF3 complex binds to specific nucleotide sequences called IFN-stimulated response elements (ISREs) in the promoters of certain genes, known as IFN stimulated genes. Discover the latest research on interferon signalling here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

Comparative Sequencing

Inter/Intra-Species: Comparative Sequencing describes the sequencing techniques that compare between and within species genomes. Discover the latest research on comparative sequencing of inter/intra-species here.

Glioblastoma Multiforme

Glioblastoma Multiforme (GBM) is a tumor that develops from astrocytes and oligodendrocytes. Here is the latest research on mechanisms that underlie GBM and associated therapeutic approaches.

© 2019 Meta ULC. All rights reserved

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma

Oncoimmunology

Jan 25, 2019

Tanner M JohannsGavin P Dunn

PMID: 30906654

DOI: 10.1080/2162402x.2018.1561106

Abstract

Neoantigens represent promising targets for personalized cancer vaccine strategies. However, the feasibility of this approach in lower mutational burden tumors like glioblastoma (GBM) remains unknown. We have previously reported the use of an immunogenomics pipeline to identify candidat...read more

Mentioned in this Paper

Glioblastoma
HLA Antigens
Interferons
Lymphocyte
Neoplasms
7
41
1
1

Similar Papers Found In These Feeds

Paper Details
References
  • References
  • Citations1
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.

Get paper from

/papers/detection-of-neoantigen-specific-t-cells/30906654